X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA SANOFI INDIA PLETHICO PHARMA/
SANOFI INDIA
 
P/E (TTM) x -1.1 38.3 - View Chart
P/BV x 0.0 7.2 0.2% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 PLETHICO PHARMA   SANOFI INDIA
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
SANOFI INDIA
Dec-17
PLETHICO PHARMA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs3954,945 8.0%   
Low Rs313,901 0.8%   
Sales per share (Unadj.) Rs604.41,081.8 55.9%  
Earnings per share (Unadj.) Rs32.5141.6 22.9%  
Cash flow per share (Unadj.) Rs51.3185.9 27.6%  
Dividends per share (Unadj.) Rs033.00 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs473.6868.8 54.5%  
Shares outstanding (eoy) m34.0823.03 148.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.44.1 8.6%   
Avg P/E ratio x6.631.2 21.0%  
P/CF ratio (eoy) x4.223.8 17.5%  
Price / Book Value ratio x0.55.1 8.8%  
Dividend payout %023.3 0.0%   
Avg Mkt Cap Rs m7,262101,862 7.1%   
No. of employees `000NA3.2 0.0%   
Total wages/salary Rs m1,5963,685 43.3%   
Avg. sales/employee Rs ThNM7,691.9-  
Avg. wages/employee Rs ThNM1,137.7-  
Avg. net profit/employee Rs ThNM1,006.5-  
INCOME DATA
Net Sales Rs m20,59824,914 82.7%  
Other income Rs m386807 47.9%   
Total revenues Rs m20,98425,721 81.6%   
Gross profit Rs m2,8185,372 52.5%  
Depreciation Rs m6421,022 62.8%   
Interest Rs m1,59311 14,483.6%   
Profit before tax Rs m9695,146 18.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1381,886 -7.3%   
Profit after tax Rs m1,1073,260 34.0%  
Gross profit margin %13.721.6 63.4%  
Effective tax rate %-14.336.6 -39.0%   
Net profit margin %5.413.1 41.1%  
BALANCE SHEET DATA
Current assets Rs m18,87714,432 130.8%   
Current liabilities Rs m11,8966,010 197.9%   
Net working cap to sales %33.933.8 100.3%  
Current ratio x1.62.4 66.1%  
Inventory Days Days3661 59.0%  
Debtors Days Days19828 694.6%  
Net fixed assets Rs m9,8617,991 123.4%   
Share capital Rs m341230 147.9%   
"Free" reserves Rs m12,33119,778 62.3%   
Net worth Rs m16,13920,008 80.7%   
Long term debt Rs m4,7060-   
Total assets Rs m33,14627,770 119.4%  
Interest coverage x1.6468.8 0.3%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.60.9 69.3%   
Return on assets %8.111.8 69.2%  
Return on equity %6.916.3 42.1%  
Return on capital %12.325.8 47.7%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Exports (fob) Rs m4,402NA-   
Imports (cif) Rs m3,136NA-   
Fx inflow Rs m4,4026,306 69.8%   
Fx outflow Rs m3,1845,257 60.6%   
Net fx Rs m1,2191,049 116.2%   
CASH FLOW
From Operations Rs m2,4374,351 56.0%  
From Investments Rs m-6,265-787 796.0%  
From Financial Activity Rs m2,490-1,884 -132.2%  
Net Cashflow Rs m-1,3371,680 -79.6%  

Share Holding

Indian Promoters % 82.7 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 4.3 14.4 29.9%  
FIIs % 5.5 14.6 37.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 10.5 71.4%  
Shareholders   10,665 15,184 70.2%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   FRESENIUS KABI ONCO.  AJANTA PHARMA  UNICHEM LAB  ALKEM LABORATORIES  ELDER PHARMA  

Compare PLETHICO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 150 Points Higher; Banking Stocks Witness Buying(Closing)

Indian share markets continued their momentum and ended the day on a positive note. Gains were largely seen in the banking sector, consumer durables sector and realty sector.

Related Views on News

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, SANOFI INDIA has posted a net profit of Rs 996 m (up 35.1% YoY). Sales on the other hand came in at Rs 7 bn (up 13.8% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 5-YR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS